NSEDCP
RIGL icon

NJ State Employees Deferred Compensation Plan’s Rigel Pharmaceuticals RIGL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$375K Hold
20,000
0.04% 320
2025
Q1
$360K Hold
20,000
0.05% 331
2024
Q4
$336K Hold
20,000
0.04% 349
2024
Q3
$324K Hold
20,000
0.04% 359
2024
Q2
$164K Sell
20,000
-180,000
-90% -$1.48M 0.02% 439
2024
Q1
$296K Hold
200,000
0.04% 378
2023
Q4
$290K Hold
200,000
0.04% 381
2023
Q3
$216K Hold
200,000
0.03% 414
2023
Q2
$258K Hold
200,000
0.04% 401
2023
Q1
$264K Hold
200,000
0.04% 395
2022
Q4
$300K Hold
200,000
0.05% 362
2022
Q3
$236K Hold
200,000
0.04% 393
2022
Q2
$226K Hold
200,000
0.04% 407
2022
Q1
$598K Hold
200,000
0.08% 254
2021
Q4
$530K Hold
200,000
0.07% 286
2021
Q3
$726K Hold
200,000
0.1% 218
2021
Q2
$868K Hold
200,000
0.12% 195
2021
Q1
$684K Hold
200,000
0.1% 226
2020
Q4
$700K Hold
200,000
0.11% 194
2020
Q3
$480K Hold
200,000
0.09% 227
2020
Q2
$366K Hold
200,000
0.07% 279
2020
Q1
$312K Hold
200,000
0.07% 275
2019
Q4
$428K Hold
200,000
0.07% 308
2019
Q3
$374K Hold
200,000
0.07% 325
2019
Q2
$522K Hold
200,000
0.09% 240
2019
Q1
$514K Hold
200,000
0.09% 263
2018
Q4
$460K Buy
200,000
+20,000
+11% +$46K 0.1% 245
2018
Q3
$578K Buy
180,000
+70,000
+64% +$225K 0.1% 259
2018
Q2
$311K Sell
110,000
-40,000
-27% -$113K 0.06% 422
2018
Q1
$531K Hold
150,000
0.09% 292
2017
Q4
$582K Sell
150,000
-140,000
-48% -$543K 0.1% 300
2017
Q3
$737K Sell
290,000
-65,000
-18% -$165K 0.13% 234
2017
Q2
$969K Hold
355,000
0.18% 180
2017
Q1
$1.18M Hold
355,000
0.22% 157
2016
Q4
$845K Hold
355,000
0.17% 206
2016
Q3
$1.3M Buy
355,000
+100,000
+39% +$367K 0.27% 121
2016
Q2
$569K Hold
255,000
0.12% 254
2016
Q1
$645K Hold
255,000
0.14% 235
2015
Q4
$773K Hold
255,000
0.16% 216
2015
Q3
$630K Buy
+255,000
New +$630K 0.14% 239